D. A. A. Owen

415 total citations
24 papers, 333 citations indexed

About

D. A. A. Owen is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, D. A. A. Owen has authored 24 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in D. A. A. Owen's work include Mast cells and histamine (11 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Effects and Assays (5 papers). D. A. A. Owen is often cited by papers focused on Mast cells and histamine (11 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Effects and Assays (5 papers). D. A. A. Owen collaborates with scholars based in United Kingdom, Netherlands and United States. D. A. A. Owen's co-authors include Carol Harvey, David F. Woodward, M. E. Parsons, Elizabeth A. Brown, R R Griffiths, R.W. Brimblecombe, W. A. M. Duncan, Barbara M. Johnston, Ewa K. Stuermer and D.F. Woodward and has published in prestigious journals such as Gastroenterology, The Journal of Physiology and British Journal of Pharmacology.

In The Last Decade

D. A. A. Owen

23 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. A. A. Owen United Kingdom 12 126 120 87 53 39 24 333
U. Braam Germany 8 185 1.5× 79 0.7× 68 0.8× 60 1.1× 17 0.4× 18 404
MG Belvisi United Kingdom 12 233 1.8× 88 0.7× 300 3.4× 178 3.4× 47 1.2× 21 592
Kristen E. Belmonte United States 13 256 2.0× 99 0.8× 360 4.1× 117 2.2× 15 0.4× 19 724
Sylvie Marc France 7 185 1.5× 41 0.3× 123 1.4× 89 1.7× 35 0.9× 9 423
P. Devillier France 10 165 1.3× 32 0.3× 285 3.3× 166 3.1× 48 1.2× 20 520
Satoshi Akahane Japan 14 149 1.2× 17 0.1× 143 1.6× 43 0.8× 32 0.8× 21 563
Karmelo M. Lulich Australia 8 102 0.8× 23 0.2× 250 2.9× 74 1.4× 41 1.1× 15 360
G. Sadeghi-Hashjin Netherlands 7 66 0.5× 44 0.4× 247 2.8× 25 0.5× 10 0.3× 8 343
J.J. Reeves United Kingdom 9 189 1.5× 50 0.4× 54 0.6× 75 1.4× 29 0.7× 12 408
Victor P. Fomin United States 13 294 2.3× 49 0.4× 122 1.4× 56 1.1× 7 0.2× 20 511

Countries citing papers authored by D. A. A. Owen

Since Specialization
Citations

This map shows the geographic impact of D. A. A. Owen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. A. Owen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. A. Owen more than expected).

Fields of papers citing papers by D. A. A. Owen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. A. Owen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. A. Owen. The network helps show where D. A. A. Owen may publish in the future.

Co-authorship network of co-authors of D. A. A. Owen

This figure shows the co-authorship network connecting the top 25 collaborators of D. A. A. Owen. A scholar is included among the top collaborators of D. A. A. Owen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. A. Owen. D. A. A. Owen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Owen, D. A. A., et al.. (2010). An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1‐ and H2‐receptors. British Journal of Pharmacology. 160(s1). S44–9; discussion S43. 1 indexed citations
2.
Gristwood, R.W., et al.. (1988). In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action. British Journal of Pharmacology. 93(4). 893–901. 9 indexed citations
3.
Owen, D. A. A.. (1987). Inflammation—histamine and 5-hydroxytryptamine. British Medical Bulletin. 43(2). 256–269. 26 indexed citations
4.
Ganellin, C. Robin, et al.. (1987). Evidence for low brain penetration by the H1-receptor antagonist temelastine (SK & F 93944). European Journal of Pharmacology. 133(1). 65–74. 11 indexed citations
5.
Brown, Elizabeth A., R R Griffiths, Carol Harvey, & D. A. A. Owen. (1986). Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1‐receptor antagonist with negligible ability to penetrate the central nervous system. British Journal of Pharmacology. 87(3). 569–578. 52 indexed citations
6.
Ganellin, C. Robin, Thomas H. Brown, G. J. DURANT, et al.. (1986). Icotidine, An Antagonist of Histamine at Both H1 and H2 Receptors. Allergy and Asthma Proceedings. 7(2). 126–133. 7 indexed citations
7.
Price, Carolyn, et al.. (1985). Dopamine agonists gastric mucosal damage blood flow and acid secretion. Digestive Diseases and Sciences. 30(4). 395. 3 indexed citations
8.
Woodward, David F., et al.. (1985). Histamine involvement in the local and systemic microvascular effects produced by intradermal substance P. Inflammation Research. 17(2). 126–130. 11 indexed citations
9.
Owen, D. A. A., et al.. (1984). Studies on cutaneous vascular permeability in the rat: Increases caused by histamine and histamine-like agents. Inflammation Research. 14(1). 39–42. 15 indexed citations
10.
Woodward, D.F., et al.. (1981). Re-evaluation of the effect of non-steroidal anti-inflammatory agents on u.v.-induced cutaneous inflammation. Inflammation Research. 11(6-7). 711–717. 15 indexed citations
13.
Finch, L, Carol Harvey, Peter E. Hicks, & D. A. A. Owen. (1977). Interaction between histamine H2-receptor antagonists and the hypotensive effects of clonidine in rats [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 59(3). 477P–477P. 6 indexed citations
14.
Owen, D. A. A., et al.. (1977). The effects of histamine on skeletal muscle vasculature in cats.. The Journal of Physiology. 265(3). 795–807. 8 indexed citations
15.
Brimblecombe, R.W., W. A. M. Duncan, D. A. A. Owen, & M. E. Parsons. (1976). The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(8). 1931–4. 28 indexed citations
16.
Harvey, Carol & D. A. A. Owen. (1976). CHANGES IN UTERINE AND OVARIAN BLOOD FLOW DURING THE OESTROUS CYCLE IN RATS. Journal of Endocrinology. 71(3). 367–369. 22 indexed citations
17.
Owen, D. A. A., et al.. (1976). Inflammation and the vascular changes due to thermal injury in rat hind paws. Inflammation Research. 6(5). 622–626. 11 indexed citations
18.
Owen, D. A. A. & M. E. Parsons. (1974). Proceedings: Histamine receptors in the cardiovascular system of the cat.. PubMed. 51(1). 123P–124P. 11 indexed citations
19.
Owen, D. A. A., et al.. (1972). The effects of Hydergine on acutely denervated cat skeletal muscle vasculature. Naunyn-Schmiedeberg s Archives of Pharmacology. 272(4). 395–401. 2 indexed citations
20.
Owen, D. A. A. & Ewa K. Stuermer. (1971). Effect of dihydroergotamine (DHG) on the capacitance, resistance and precapillary sphincter vessels of denervated cat skeletal muscle.. PubMed. 42(4). 655P–656P. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026